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Key points
• A mathematical model is developed for predicting the effects of repetitive intermittent
umbilical cord occlusions of variable severity on fetal cardiovascular and metabolic
responses.
• Our model is capable of reproducing the salient features observed in the various ovine
fetal experimental models such as fetal heart rate (FHR) decelerations, mean arterial
blood pressure (MABP) responses, pH, lactate and base deficit (BD) dynamics with
worsening mixed respiratory and metabolic academia.
• Our model also shows that the FHR variability, combined with secondary features of
FHR (such as overshoots) and MABP decline can serve as indicators of worsening fetal
acidemia with increased BD.
Abstract Fetal acidemia during labour is associated with an increased risk for brain injury
and lasting neurological deficits. This is in part due to the repetitive occlusions of the
umbilical cord (UCO) induced by the uterine contractions. While fetal heart rate (FHR)
monitoring is widely used clinically, it fails to detect fetal acidemia. Hence, new approaches
are needed for early detection of fetal acidemia during labour. We built a mathematical
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model of the UCO effects on FHR, mean arterial blood pressure (MABP), oxygenation
and the metabolism. Mimicking fetal experiments, our in silico model reproduces salient
features of experimentally observed fetal cardiovascular and metabolic behavior including
FHR overshoot, gradual MABP decrease and mixed metabolic and respiratory acidemia
during UCO. Combined with statistical analysis, our model provides valuable insight of the
labour-like fetal distress and guidance for refining FHR monitoring algorithms to improve
detection of fetal acidemia and cardiovascular decompensation.
Abbreviations FHR, Fetal Heart Rate; MABP, Mean Arterial Blood Pressure; UCO,
Umbilical Cord Occlusions; BD, Base Deficit, RMSSD, Root Mean Square of the Successive
Differences.
I. INTRODUCTION
One of the main issues during childbirth is the possibility of developing severe fetal
acidemia (pH < 7.0) caused by umbilical cord occlusions (UCO) due to repetitive uterine
contractions. The resulting increased risk of schemic brain injury can be associated with
acidemia [1]. The sudden compression of the umbilical cord leads to fetal hypertension
and fetal heart rate (FHR) decelerations, which are mediated through chemoreflex and
sympathetic stimulation [2–4]. Fetal oxygen delivery via umbilical cord is interrupted
and leads to hypoxemia and acute cerebral hypoxia [5–10]. In addition, FHR reduction and
oxygen deficiency also activate sympathetic and parasympathetic brainstem centers resulting
in changes of afferent and threshold efferent firing rates [11, 12]. These activities, in turn,
via efferent signaling, regulate FHR and systemic arterial blood pressure. Furthermore,
prolonged cord compression and/or repeated cord compressions may cause accumulation of
metabolites, such as CO2 and lactate, in the fetus, which contributes to acidemia [4, 13], as
well as prolonged cerebral hypoperfusion [14]. A comprehensive discussion on the dynamic
changes of the fetal circulation and blood flow distribution during hypoxia and asphyxia due
to different experimental disturbances can be found in a review paper [15].
Beyond the physiological understanding of the general process, a clinically relevant ques-
tion is how to monitor and predict the levels of fetal acidemia based on the available clinical
data so that the fetal brain can be protected by medical intervention. Since direct continuous
measurements of acidemia from fetal blood are not possible clinically and measurements can
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only be done intermittently in an animal model, attempt has been made to use statistical
approaches to make prediction of acidemia based on FHR [16]. However, current FHR-based
clinical algorithms do not provide an accurate prediction of acidemia [17]. This is because
there is no a priori knowledge of which FHR properties reflect acidemia best. Therefore,
a mechanistic modeling approach that can identify FHR properties related to acidemia will
provide valuable insights that are useful for developing more effective diagnostic tools.
Mathematical modeling and simulation are useful alternatives to experiments, especially
when they are too difficult or too expensive. One of the advantages of mathematical models
is that they allow us to conduct parametric studies easily. The physical quantities can
be easily tracked. A popular mathematical model in describing the cardiovascular system
coupled with the central nervous system has been proposed by Ursino [18], followed by
many related studies that can reproduce and predict the cardiovascular responses in various
systems successfully [19–23]. The drawback is that usually the biological system has a large
number of parameters, some of which are difficult or impossible to measure. This makes
analysis difficult and can easily introduce uncertainties and errors in the model. A similar
cardiovascular mathematical model was used to explore physiological mechanisms in postural
change and related physiology problems [24–26]. The common ground of those models
shared is the electric circuit analog, but in the meantime, Olufsen’s group also performed
mathematical analysis and sensitivity analysis [26] to better understand the model dynamics
and the impact of the parameters on outputs. A recent review on various models can be
found in [27].
The metabolic dynamics formulated using a deterministic approach, is based on the car-
diovascular model by Olufsen’s group and a similar (local) sensitivity analysis. A regulation
model is incorporated to provide cardiovascular feedback with respect to the arterial pres-
sure and substrate (oxygen, lactate, glucose · · · ) concentrations via central neural system,
following the works in [18, 21, 23, 28]. Details are revealed in section II. Furthermore, cur-
rent modeling includes biochemical processes with proper substrate transfer between blood
and organs is incorporated. As indicated by the experiments [13, 29], metabolic dynamics
is closely related to the development of acidemia in fetal sheep and accumulation of wastes,
such as CO2 and lactate, contributes to the decline in pH. A mathematical model can contin-
uously display both in time and space the evolution of implicated molecular concentrations,
unlike measurements.
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The present mathematical model consists of three elements: a lumped parameter model
for the cardiovascular circuit coupled with nervous regulation and reciprocal perfusion–
metabolism influences. This model is used to investigate the effect of UCOs on FHR, MABP
pattern and acidemia development. Our model reproduces some of the patterns observed
in animal experiments such as FHR overshoot, deceleration, MABP and pH decline, lactate
and CO2 increase. More importantly, we have confirmed correlation between RMSSD, a
statistical measure of FHR variability and critical levels of lactate and pH. On the other
hand, we have also shown that one has to be careful when applying RMSSD as a predictive
index. In particular, a variable window size should be used to compute RMSSD when the
occlusion duration varies instead of blindly applying standard signal processing techniques.
The rest of the paper is organized as follows. The model equations are given in section
II for different components. In section III, model calibration is discussed and a sensitivity
analysis is carried out to identify the most sensitive parameters in the mathematical model.
Numerical results motivated by different fetal experiments are presented in cardiovascular
responses in section III B and metabolic dynamics in section III C. Statistical analysis based
on contingency table and RMSSD are discussed in section III D. Finally a summary and
conclusion are given in section IV.
II. MATHEMATICAL FORMULATION
A. Cardiovascular system
Our model includes both maternal and fetal circulations. Similar to previous stud-
ies [24, 28], we use the electrical circuit analogs, where pressure p(t) is analogous to voltage,
volumetric flow rate q(t) to the current, and compliance Ci to capacitance. In addition, the
resistance R accounts for the viscous pressure drop in each element of the circuit. A schemat-
ics of the model with individual components is given in Fig. 1. We model the heart (both
in the maternal and fetal circulation) as an effective left ventricle [24], which has two ideal
valves on two sides. Two compartments are used to model the branching flow before and
after the ventricle, where pa and pv are computed [24]. Our model hearts are effective pumps
that produce the desirable cardiovascular outputs to maintain both maternal and fetal blood
circulations. The fetal systemic circulation is modeled as one compartment with subscript
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FIG. 1. Illustration of model setup. Our model includes two circulatory networks: maternal
circulation (top) and fetal (bottom) circulations. Resistors R and compliances C are indicated,
arrows giving blood flow direction, similar to [28]. In this mathematical domain sketch, ‘a’ stands
for artery, ‘v’ for vein, ‘um’ for umbilical cord, ‘mc’ for systemic part, ‘c’ for cerebral part, ‘ut’ for
uterine and ‘ivs’ for intervillous space.
‘mc’ (Fig. 1). While the remaining fetal circulation is considered as one compartment, the
umbilical cord and cerebral circulation are modeled separately with arteries and veins [28].
The maternal circulation system is coupled with the fetal circulation system through par-
tial oxygen pressure in intervillous space of the placental connected to the umbilical cord.
We adopt an oxygen transport model [30] and the oxygen distribution in the circulation
systems is given by the conservation of mass [28] including convection, diffusion and reac-
tion (metabolic uptake and consumption) in the circuit. The blood pressure and oxygen
content are coupled through a regulatory model on heart rate by the vagal–sympathetic
control [18, 28].
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The basic equations predicting blood pressure and flow can be obtained by computing
the volume V and its change for each compartment, V = Cp, where C is the compliance,
which plays the role of capacitance and p is the pressure for the corresponding compartment.
The change of volume in each compartment is then given by
dV
dt
= qin − qout. (1)
Analogy to the Ohm’s law provides a linear relation between pressure p and flow rates q
qi =
pin − pout
Ri
, (2)
where the subscript i stands for a (artery), v (vein), um (umbilical), c (cerebral; Fig.1). In
this study only the resistance in system is modelled while inertia is neglected [24] . With
compliances kept as constants, the equations for pressure change are given by
Ci
dpi
dt
= qin − qout. (3)
The fetal heart is modeled similarly as the left ventricle used in the study [24] (a combined
ventricle) where the details in pulmonary circulation and the ductus arteriosus are ignored.
The rate of volume change [24], is given by
dVh
dt
= smvqmv − savqav, (4)
where smv and sav are the indicator functions for valves with zero and one for a closed and
open valve, respectively. Conservation of volume V requires that dVtotal/dt = 0, where Vtotal
is the total volume of all compartments [24]. To model the branching before and after the
ventricle, flow rate satisfies the law of mass conservation [24, 25, 28], given by
qav = q
a
c + qmc + q
a
um, (5)
qmv = q
v
c + qmc + q
v
um. (6)
The pressure-volume relationship is given by [24]
ph = a(Vh − b)2 + (c(t)Vh − d)g(t), (7)
where Vh, ph, and c(t) are the heart volume, pressure, and contractility, respectively. Here
g(t) = f(t)/f(tp) is an activation function that controls periodic oscillation. In maternal
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circulation, c(t) = cm is assumed to be a constant, while in fetal circulation c(t) = cf (t) is
regulated by β sympathetic activity (see 35 below) and f(t) is given by [24],
f(t) =
 pp(H)
tn(β(H)−t)m
nnmm((β(H)−α)/(m+n))m+n , 0 ≤ t ≤ βh(H),
0, βh(H) < t ≤ T
where H is the heart rate controlled by the nervous system (Section II D), n and m char-
acterize the contraction and relaxation phases, tp and pp are the peak time and peak value
of the activation, and βh(H) is the time when the valve is closed and flow stops. According
to [24], the expressions for tp, pp and βh(H) are given by
tp = tmin +
θν
Hν + θν
(tmax − tmin), (8)
pp = pmin +
Hη
Hη + φη
(pmax − pmin), (9)
βh(H) =
n+m
n
tp(H) (10)
where ν and η are parameters that control the steepness of the sigmoidal change. Blood is
pumped out from heart into arterial system and flows through each individual compartment
such as the umbilical cord, cerebral and systemic compartment in fetal circulation system,
and returns to the heart via vein (Fig.1).
B. Metabolic model
The model for oxygen distribution is based on mass conservation [28, 30]. Oxygen con-
centration [O2] in each compartment is given by the following equations
d ([O2]ivsVivs)
dt
= qivs([O2]
m
in − [O2]ivs)− SO2,d, (11)
d ([O2]umVum)
dt
= qaum([O2]in − [O2]um) + SO2,d, (12)
d ([O2]cVc)
dt
= qac ([O2]in − [O2]c)−Omet,c, (13)
d ([O2]mcVmc)
dt
= qmc([O2]in − [O2]mc)−Omet,mc, (14)
where the subscript ivs stands for the intervilious space. Vi is the blood volume in compart-
ment i, qi is the flow through the compartment. The feeding oxygen concentration in fetus
is given by
[O2]in =
[O2]umq
a
um + [O2]mcqmc + [O2]cq
a
c
qav
, (15)
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while [O2]
m
in = 0.2 is fixed in maternal part [30]. SO2,d and Omet,i account for diffusion and
metabolic uptake, respectively [28, 30]. The oxygen diffusion in the placenta is determined
by the oxygen partial pressure difference between the intervillous space and the umbilical
cord (or umbilical microcirculation),
SO2,d = D(POivs2 − POum2 ) (16)
with PO2 being the partial oxygen pressure andD is the mass transfer coefficient. The oxygen
concentration is related to the oxygen partial pressure by the following relation (subscript
omitted)
[O2] =
αHbS(PO2)
100
+ βPO2 , (17)
where α represents the maximum binding capacity of hemoglobin, Hb the hemoglobin con-
centration and β the content of dissolved oxygen. In addition, S in (17) is given by
S(PO2) =
100
1 + c1(PO2
3 + c2PO2)
−1 . (18)
The metabolic uptake in equations (13, 14) is a constant when the oxygen supply is sufficient.
When oxygen concentration drops below a threshold concentration, [O2]th, it is assumed to
be a linear function of the oxygen concentration. Combining the two, we have
Omet =
 Omet,0, [O2] ≥ [O2]th,Omet,0 +K([O2]− [O2]th), [O2] < [O2]th
for all fetal compartments [28]. In maternal circulation, we assume that oxygen supply is
sufficient [28, 30].
As an indicator for asphyxia (due to prolonged UCO typically), we model CO2 distri-
bution, using the law of mass conservation equation for CO2 in each fetal compartment as
following
d ([CO2]umVum)
dt
= qaum([CO2]in − [CO2]um) +DCO2(PCO2 ivs − PCO2um), (19)
d ([CO2]cVc)
dt
= qac ([CO2]in − [CO2]c) +Mc, (20)
d ([CO2]mcVmc)
dt
= qmc([CO2]in − [CO2]mc) +Mmc +MpH, (21)
where [CO2]in is given by
[CO2]in =
[CO2]umq
a
um + [CO2]mcqmc + [CO2]cq
a
c
qav
. (22)
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DCO2 is the diffusion coefficient, PCO2 the partial pressure of carbon dioxide, Mi the pro-
duction rate of [CO2]i and MpH is given by
MpH = 0.1
([H+]− 40)2
1 + ([H+]− 40)2 . (23)
We assume that CO2 is cleared in the placenta and PCO2
ivs = 40 mmHg is fixed. In addition,
we assume that the production of carbon dioxide is related to the metabolic rate of oxygen
and MCO2 = KOmet [31] with a constant K (taken to be 0.2 in this study). The partial
pressure of carbon dioxide relates to the concentration linearly as [32]
[CO2] = KCO2PCO2 + kCO2 , (24)
where KCO2 and kCO2 are scaling constants.
To assess the acidity level [13, 17, 33], lactate and pH values that are usually measured in
fetal animal experiments, are include in our model (Fig. 2). Following [34, 35], we consider
FIG. 2. Illustration of the simplified metabolic process in certain compartment in the model. Left
(right) column stands for artery (vein).
pyruvate, glucose and lactate related metabolic pathways in the fetal body or systemic com-
partment, in particular, anaerobic glycolysis, pyruvate reduction, glycoeogenesis, glycogen
synthesis and breakdown, lactate oxidation, lactate buffering. The equations for glucose
(GL), lactate (LA) and pyruvate (PY), from literature [35], which is solving a coupling
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between cardiovascular and metabolism for excises, are
V
d[GL]
dt
= q (GLin − [GL]) +mφGY b PS
PS + kGY b
[GY]
− φGLb PS
PS + kPSGLb
[GL]
RS/kRSGLb + 1
− φGY s [GL]
PS/kGY s + 1
(25)
V
d[PY]
dt
= q (PYin − [PY]) + 2φGLb PS
PS + kPSGLb
[GL]
RS/kRSGLb + 1
− φPY r RS
RS/kPY r + 1
[PY ]− φPY o RS
RS/kPY o + 1
[PY]
+ φLA
1
RS/kLAo + 1
[LA] (26)
V
d[LA]
dt
= q (LAin − [LA]) + φPY r RS
RS/kPY r + 1
[PY]− φLA 1
RS/kLAo + 1
[LA] (27)
where the first term on the right hand side of the equations models convective exchange, [∗]in
is the arterial concentration (Eq. (15)), PS = [ADP ]/[ATP ] and RS = [NADH]/[NAD],
which are picked as constants in [34] as 0.13 and 0.11 respectively, GY is Glycogen whose
concentration is much larger than the rest (table 2 in [34]) and hence is treated as a constant
in current model, φ[∗] is the reaction rate accordingly and k[∗] are constants. In addition,
the subscripts are short names for different stoichiometry GY b(GY → mGL), GY s(mGL→
GY), GLb(GL→ 2PY), LAo(LA→ PY), PY r(PY → LA).
A close inspection reveals that the kinetic coefficients in front of substrates are effec-
tively (unknown) constants and we tune those to fit the experimental measurements. Using
simplifying notations, we obtain
dV [GL]
dt
= q (GLin − [GL]) +K1 −K2[GL], (28)
dV [PY]
dt
= q (PYin − [PY]) +K3[GL]−K4[PY] +K5[LA], (29)
dV [LA]
dt
= q (LAin − [LA]) +K6[PY]−K5[LA], (30)
where Ki are constants. Constant concentrations for GL,PY,LA are imposed in cerebral
and umbilical cord compartments (Table II). This needs to be modified when asphyxia is
fully developed [14], which is beyond of the scope of current paper.
The effect of pH is not included in lactate equation (30), which is modified by adding the
production due to deprotonation of lactic acid,
dV [LA]
dt
= q (LAin − [LA]) +K6[PY]−K5[LA] +K10[H+]. (31)
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In addition, we add an equation for [H+] which takes into account two sources of acidity:
lactate dehydrogenase and CO2 accumulation, since under umbilical cord occlusion, experi-
mental reports show significant waste accumulation (especially CO2). We use the following
equation [36]
dV [H+]
dt
= q
(
Hin − [H+]
)
+K7[LA] +K8[CO2]−K9, (32)
where K7 and K8 are coefficients for [H
+] accumulation due to increased level of lactate and
CO2; K9 accounts for the ATP consumption among other effects, which is assumed to be an
effective constant that helps to restore normal [H+] level.
C. Effectors
Following [18, 23], there are a few effectors in the model. For autoregulation in fetal
brain, we use the following equation [23],
dRcmc
dt
=
R∗cmc −Rcmc
τRcmc
(33)
where
R∗cmc =
Rcmc,min +Rcmc,maxe
(
[O2]a−[O2]a,n
kcmc
)
1 + e
(
[O2]−[O2]a,n
kcmc
) (34)
Once the oxygen is low, the reduced resistance will allow more flow to the brain. This acts
in opposite direction as the one in systemic circulation (Eq. 37).
The fetal heart contractility cf (t) in Eq. (7) is regulated by sympathetic nervous control
that targets mainly β-adrenergic receptors with a firing rate fsh (Section II D).
4c = Gc ln
(
fsh − fes,min + fs1
fs1
)
(35)
which is set to zero if fsh < fes,min.
The compliance Cv and resistance Rmc [23] are regulated by sympathetic nervous system
that targets mainly α-adrenergic receptors with a firing rate fsp,
4Cv = Gv ln
(
fsp − fes,min + fs1
fs1
)
, (36)
4Rmc = Rmc,min +Rmc,maxe
(
fsp−fsp,n
krmc
)
1 + e
(
fsp−fsp,n
krmc
) . (37)
11
D. Afferent/efferent pathways
Changes in blood and oxygen partial pressures trigger nervous responses via baro- and
chemoreceptors. Their effects on heart rate have been described [18, 21, 23], modified in the
present work, and incorporated in the model. In particular, the period of heart pumping
motion T , is given by T = T0 +4Ts+4Tv, where T0 = τ0 +Ts0 +Tv0 with τ0 an offset term,
Ts,v0 the baseline values of sympathetic/vagal contribution and 4Tv,4Ts are determined by
d4Tv(t)
dt
=
1
τT,v
(−4Tv(t) +GT,vfv(t−DT,v)− Tv0) , (38)
d4Ts(t)
dt
=
1
τT,s
(−4Ts(t) + G¯T,sfs(t−DT,s) +G′T,s (fs − fs0)) . (39)
Here τT,v and τT,s are the respective time constant, GT,v and G¯T,s, G
′
T,s the gains, DT,v and
DT,s the delay of the vagal and sympathetic responses. In the results presented in this paper,
they are set to zero. At equilibrium state, the second and third terms in the right hand side
of Eqs. 38 and 39 vanish, which leads to 4Tv → 0 and 4Ts → 0, so that the baseline period
is recovered at T = T0. Finally, fv and fs are given by
fv = Wb,v
fev,min + fev,maxe
(fab−fab,n)/kev
1 + e(fab−fab,n)/kev
+Wc,vfac + fvh, (40)
fs = ln
(
fsh − fes,min + fs1
fs1
)
, (41)
with
fvh =
fvh,min + fvh,maxe
(PO2c−PO2c,0 )/kvh
1 + e(PO2c−PO2c,0 )/kvh
− fv,o, (42)
fsh/sp = fes,∞ + (fes,0 − fes,∞)ekes(−Wb,sh/spfab+Wc,sh/spfac−fsh/sp,o), (43)
where fab and fac are the afferent baro- and chemoreceptor firing rates, respectively, and
fsh/sp,o is the hypoxia offset that creats a threshold for sympathetic response. In addition,
fs = 0 when fsh/sp < fes,min, and fs = fes,max when fsh/sp exceeds a threshold value fes,max.
Furthermore, the baro- and chemoreceptors afferent firing rates fab and fac are governed by
the following first order ODE [23]
dfab
dt
=
f ∗ab − fab
τab
,
dfac
dt
=
f ∗ac − fac
τac
,
dp¯
dt
=
pa − p¯a
Np
(44)
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where according to [37]
f ∗ab =
fab,min + fab,maxe
p¯−pn
τkab
1 + e
p¯−pn
τkab
, (45)
f ∗ac =
fac,max + fac,mine
PO2a
−PO2n
τkac
1 + e
PO2a
−PO2n
τkac
(
K¯ ln
(
PmcCO2
PmcCO2,n
)
+ 1
)
, (46)
p¯a =
1
Np
∫ t
0
pa(s)e
−ψ(t−s)ds, (47)
where p¯a is the mean arterial blood pressure. The formula used in [23] is recovered when
PmcCO2 is in the normal range and fac rises when P
mc
CO2
increases. Unless otherwise stated,
K¯ = 1.
The normalization factor Np is introduced to ensure that the correct mean arterial blood
pressure is calculated [24],
Np =
∫ t
0
e−ψ(t−s)ds =
1− e−ψt
ψ
. (48)
The offset value fsh/sp,o in Eq. (43) is determined by
dfsh/sp,o
dt
=
f ∗sh/sp,o − fsh/sp,o
τisc
(49)
where
f ∗sh/sp,o =
fsh/sp,min + fsh/sp,maxe
(
PO2a
−PO2a,n
kisc,sh
)
1 + e
(
PO2a
−PO2a,n
kisc,sh
) . (50)
Due to hypoxemia in fetal circulation, the vagal firing rate increases, hence decreasing FHR.
The sympathetic response has the opposite effects [11, 38].
To take into account of the apparent mutual inhibition of sympathetic and vagal nerves,
we model the sympathetic gain G¯T,s as a sigmoidal function of vagal firing rate fv,
G¯T,s =
δGT e
fv−fvn
τgs
1 + e
fv−fvn
τgs
, (51)
which shows the sympathetic gain tends to the minimal value as the vagal firing rate increases
due to the inhibition effect as mentioned. Similarly, we introduce the following for the vagal
gain GT,v
GT,v =
GTv,max +GTv,mine
− fsh−fshn
τgv
1 + e
− fsh−fshn
τgv
, (52)
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It was pointed out [39–41] that the gains may depend on pressure and other dynamic vari-
ables. For simplicity, they are chosen as constants in current model. Meanwhile, we assume
that the sympathetic and vagal activity in system are mutually inhibitory and mediated
via the chemoreceptors and baroreceptors (see (51) and (52)), which is consistent with the
physiological explanations [9].
In summary, the above set of equations form a coupled system. Due to the nonlinear
nature of the equations, they are solved numerically using Matlab solver ode15s and sub-
routines sens sys and sens ind, which are given in [42], for sensitivity analysis.
III. RESULTS AND DISCUSSION
Two control parameters are used to measure UCO severity: 1) the ratio between the
occlusion and the recovery durations and 2) the occlusion degree (partial or complete). As
we show below, the effects of these parameters on FHR are significant.
A. Model calibration: baseline values and sensitivity analysis
As in many cardiovascular models [18, 24, 28], the parameter space is large. Most of the
parameter values are obtained from the literature and the remaining ones are calibrated by
comparing our model outputs with available experiments. For example, GTv ∼ 0.04 is taken
instead of 0.09 used for the adult model [18, 28] to reflect the fact that the vagal control in
fetus is not as mature. G′T,s, δGT are tuned to achieve a reasonable reduction in FHR for
fetus. The values of adjusted parameters are given in Tables I and II.
1. Baseline case
Several important and clinically relevant quantities are listed in Table III, which is the
baseline case used for our model calibration. The predicted values from our model are
consistent with experimental data. At the onset of a complete UCO, the flow rate in umbilical
cord qa,vum = 0 and O2 exchange SO2,d = 0 in the corresponding transport equations (Section
II). The flow is stopped in the umbilical cord compartment and the O2 and CO2 cannot be
delivered continuously between placental and fetal circulations. Mild and moderate UCOs
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represent partial occlusions, where the passed flow is set to be 50% and 25% of the normal
case respectively [33]. The severe case refers to as the complete occlusion regarding the
degree.
From the experimental point of view, FHR and MABP are two important quantities
often used in modeling and monitoring fetal acidemia with FHR being the single quantity
available clinically. One important feature of FHR in experiments with repetitive UCOs is
its significant drop during occlusions. In our model it is assumed that the sympathetic and
vagal activities are mutually inhibitory and mediated via baro- and chemoreceptors (Eqs. 51
and 52) [9]. FHR does not change markedly when these mechanisms are blocked [23].
FHR overshoot and MABP decline are determined by systemic vascular resistance, my-
ocardial contractility, and venous compliance under the central nervous control as proposed
in the literature [23]. We tune the parameters Gc and Gv in Eqs. (35) and (36) for the
myocardial contractility and venous compliance, respectively, to achieve FHR overshoot and
MABP decline comparable to experimental data. In most cases, sufficient control is achieved
with Gv = 0, namely, the venous compliance is chosen as a constant [24]. However, for 1:5
UCO, a nonzero Gv is used to reproduce experimental data [3, 29].
2. Sensitivity analysis
We carry out a local sensitivity analysis on model parameters according to [26], using
Matlab subroutines, sens sys and sens ind [42].
Suppose the system of equations can be written as
dX
dt
= F (X, t,p), (53)
where X denotes the state variables, and p = [p1, p2, · · · pn] stands for the parameters. Then
the relative sensitivity matrix is defined as
Sij(t,p)|p=p0 =
∂Xi(t, p)
∂pj
pj
Xi(t, p)
|p=p0 , pj, Xi 6= 0. (54)
We compute a maximum relative sensitivity
Sj = max
i
(
max
k
Sij(t, p)
)
|p=p0 . (55)
We conduct simulations over a period of 500 seconds during which data were recorded.
A ranking of parameter sensitivity (Fig. 3) and associated histogram (Fig. 4) illustrate
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the distribution of most to least sensitive parameters. Some parameters appearing in the
regulation model are most sensitive. Many kinetic coefficients appear to be less sensitive [45].
We listed top 10 most sensitive parameters in table IV with their effects.
Our simulation approach differs from that of [26], in which high quality data were avail-
able. In that case, an optimization procedure is used to fit model output to experimental
data. The sensitivity analysis further helps to reduce the computational cost as optimiz-
ing the most sensitive parameters suffices to obtain robust results. Unfortunately, we do
not have high quality experimental data as in [24] at this stage. Our sensitivity analysis
can only point out most important controlling parameters that can guide potentially future
experiments.
B. Cardiovascular dynamics: FHR and MABP hehavior
We studied the one minute occlusion scenario, a clinically relevant case. The recov-
ery time for one minute complete occlusion, that is, the UCO frequency, influences the
system behavior significantly. Based on our in silico experiments, for 1:2.5 UCO, FHR
overshoot appears after about two and half hours and acidosis develops, as demonstrated in
vivo [3, 4, 29]. In contrast, 1:5 UCO scenario does not show any significant FHR overshoots
and acidosis, as shown in the literature [29]. The numerical results displayed in Fig. 5,
show the typical time variations of FHR and MABP at the early and late stages of occlu-
sion, respectively. For 1:2.5 UCO, FHR deceleration appears once the occlusion starts. The
pronounced FHR overshoot occurs only after a delay of approximately 3 hours, in agreement
with experiments [29]. This is accompanied by an eventual decline in MABP after approxi-
mately 2 hours. At the early stage of the occlusions, MABP rises as soon as the occlusion
starts [4, 17]. The inset in the bottom panel of Fig. 5 (for 1:5 UCO) shows that MABP
rises during each occlusion period, even after numerous repetitive occlusions, as expected,
but this initial rise tends to disappear in 1:2.5 UCO (left bottom panel). This is again in
agreement with experiments [43], hypotension being expected when pH drops below 7.2.
The difference in 1:5 and 1:2.5 UCOs indicates that with a sufficient time for recovery, the
regulation is able to maintain the blood pressure level and avoid instability. The detailed
mechanism is still unknown and in the real situation, the regulatory functions represented by
Eqs. (35) and (36) may depend on time-dependent or memory-related factors. Overall, the
16
FIG. 3. Results of sensitivity for 70 parameters used in the model. The vertical axis is calculated
based on Eq. (55).
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FIG. 4. Histogram of ranked parameters showing the distribution from most to least sensitive
parameters.
results in Fig. 5 demonstrate a reasonable agreement between experimental and numerical
data. We will compute the correlation of FHR, MABP, and acidosis in Section III D, as well
as the output of the metabolic model.
In addition, intermediate rise occurs typically in FHR and MABP in each occlusion for
1:2.5 UCO, when the FHR overshoot is pronounced. Similar intermediate rise was reported
in [3], where in the UCO 1:2.5 group, FHR initially recovers after the occlusion but rapidly
falls again before returning to the baseline value eventually. In our case, the trend is similar
but it appears earlier than experiments, with a relatively larger magnitude. We suspect that
it is caused by some system delay factor. Eqs. 38 and 39 contain delay variables DTv and
DTs . These are set to zero here because: 1. the delay model in the literature was developed
for adults and the correct parameter values are unknown for fetuses; 2. computational cost
is much higher for a delayed differential equation system for 4-hour simulations rather than
a few minutes as in [24]). In addition, this transient growth due to delay does not seem to
affect the general feature of our model outcome including the metabolic dynamics (reported
below).
Fig. 6 displays the numerical results of FHR and MABP for variable UCOs. Complete
UCO with varying frequency were motivated by experiments carried out in [13]. The FHR
overshoot occurs only after a delay of more than two hours for the 1:2 UCOs, and MABP
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FIG. 5. Numerical results of FHR and MABP for 1:2.5 and 1:5 UCO. Numerical results
for four hours of occlusions with 1:2.5 UCO (left) and 1:5 UCO (right). Gc = 0.27 and Gv = −0.67
are used in simulation with 1:5 UCO. The dashed lines in the upper left panel divide the time
periods into four one-hour windows. The first dashed line marks the beginning of the occlusions.
The middle row displays a zoom of 5 (left) and 10 (right) minute windows for each case at the
beginning of the occlusion, and the bottom row 5 (left) and 10 (right) minute windows near the
end of occlusions. The black bar indicates the occlusion duration. The inset of the right bottom
panel shows that MABP rises slightly at the beginning of each occlusion, and then declines.
declines from the second hour for 1:3 UCOs. This is consistent with Fig. 5 in that relatively
small frequency promotes the MABP decline and FHR overshoot. Constant frequency UCOs
with varying degrees mimic experiments in [38]. Mild occlusion has little effect, but moderate
occlusion decreases FHR (∼ 10 mmHg) to lesser extent to complete UCOs (∼ 70 mmHg). As
in [38], after two hours of severe UCOs, pH drops below 7.0. Therefore, the FHR overshoot
instability may be correlated with the worsening acidemia.
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FIG. 6. Numerical results of FHR and MABP for variable UCO. Left panel: Complete
UCO with varying occlusion frequency (1:5 UCO for the first, 1:3 for second, and 1:2 for the third
and fourth hours). Right panel: Constant frequency UCOs with varying occlusion degree (mild
occlusion during the first, moderate during the second, and severe during the third and fourth
hours). Dashed lines are inserted to divide the periods into four windows, each representing one
hour. The left dashed line marks the beginning of occlusions. The middle row represents 5-minute
windows at the beginning of the occlusion, and the bottom row 5-minute windows near the end of
occlusions. The black bar indicates the occlusion duration.
C. Metabolic dynamics
To assess the fetal acidemia, a simplified metabolic model is coupled with the cardiovas-
cular model to evaluate pH as well as BD defined by Eq. (56) (see also [13])
BD = −(0.02786PCO210pH−6.1 + 13.77pH− 124.58). (56)
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FIG. 7. Numerical results of pH, lactate, PCO2 and BD for 1:2.5 and 1:5 UCO. Time
variations of pH, lactate, PCO2 in the systemic compartment and BD for 1:2.5 UCOs (left) and
1:5 UCO (right). The ′◦′ symbol represents the mean values over 5 minutes after occlusion begins.
The ′+′ symbol represents experimental data (table 1 in [4]).
In particular, we computed the variations of lactate, [H+] and PCO2 in the systemic com-
partment to compare with the experimental data.
Fig. 7 shows several experimentally measurable quantities over 4-hour occlusions. Agree-
ment is shown when comparing with the data extracted from [4]. Corresponding to the FHR
overshoot instability for 1:2.5 UCO in Fig. 5, we find that pH drops below 7.00 and lactate
accumulates beyond 10 mM. On the other hand, pH remains in the normal range for 1:5
UCOs, even after four hours of repeated occlusions [4, 29]. pH, lactate and PCO2 remain
close to baseline values. The results depicted in Fig. 8 for variable UCOs captured the ex-
perimental data trend. Relatively low-frequency UCOs and completely occluded UCOs have
greater influence than those with higher frequency or partially occluded UCOs. The fetal
acidosis occurs for severe UCOs, indicated by the BD values and FHR overshoot instability.
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FIG. 8. Numerical results of pH, lactate, PCO2 and BD for variable UCOs. Time
variations of pH, lactate, PCO2 and BD in the systemic compartment for complete UCO with
varying frequency (left column; 1:5 UCO for the first, 1:3 for second, and 1:2 for the third and
fourth hours) and UCO of varying degree with constant frequency (right column: mild occlusion
during the first, moderate during the second, and severe during the third and fourth hours). In
the simulations displayed by the left column, K7 = 35 × 10−6 s−1 in Eq. 32 and K6 = 5 s−1 are
chosen to match with the experimental pH variation; kCO2 = 0.008 in Eq. 24 is chosen to match
the baseline value of PCO2 = 52.7± 0.9 mmHg in the experiments [13]. The remaining parameters
are given in Tables I and II.
In an attempt to quantify the relationship of these variables, we compute the correlations
between relevant quantities in Section III D.
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D. Statistical Analysis
We begin this section by computing the contingency table for each case discussed earlier.
In order to make a direct comparison with experimental data, we also present some analysis
on RMSSD, an index of vagal modulation of heart rate variability.
We examined correlations between acidemia quantified by BD and lactate on one hand
and FHR and MABP on the other. Due to the cyclical nature and time dependency, classical
Pearson correlation is not applicable to the data considered here. Therefore, we discretize
the original signal into binary time sequences with 1 indicating the occurrence of an anomaly
and 0 otherwise. An anomaly is defined as an event when an observation occurs outside
an estimated confidence interval of long term average. We use the mean µ˜ and standard
deviation σ˜ to set a threshold value, µ˜± 2σ˜, in order to sort out the relevant quantities. For
example, when the FHR (or BD or lactate) is larger than the upper bound threshold value
µ˜ + 2σ˜, these quantities are set to 1, otherwise to zero. Similarly, when MABP is smaller
than the lower bound of the threshold value µ˜−2σ˜, the MABP is set to 1, otherwise to zero.
Contingency tables are then constructed for each pair based on the simultaneous occurrence
of 1s and 0s.
For 1:2.5 UCOs, representative tables are constructed by taking the last two hours of
simulation data, given in Table V. The counts in each cell record the total number of
occurrence for one combination between two discretized time sequences. For example, the
first cell in each table records the total numbers of normal occurrence in both time series.
To search possible correlations among FHR, MABP, lactate, and BD, two statistical tests
are carried out. The first is the traditional Chi-square test and the second is on the odds ratio
derived from each contingency table. Both tests reject the hypothesis that these variables
are independent with very small p-values (p < 0.0001). Therefore, we conclude that the
anomalies in these sequences are indeed correlated with each other. Same conclusion can
be drawn for UCOs with varying frequencies (Table VI). These findings are consistent with
our results in Sections III B and III C, as FHR overshoot, MABP declines, and lactate level
increase becomes significant when large BD value appears near the end of the occlusions.
However, our results from Table VII for UCOs with variable occlusion degrees suggest
that contingent table along may not be sufficient to reveal the subtle relationship among
FHR and MABP and BD. Following [11, 38, 48]) via Eq. 57, we compute RMSSD based on
23
0 50 100 150 200 250
0
50
100
150
 
 
0 50 100 150 200 250
50
100
150
200
F
H
R
 (b
pm
)
M
A
B
P
 (m
m
Hg
)
fixed frequency
0 50 100 150 200
0
5
10
15
20
time (min)
 
 
RMSSD (s)
BD (mEq/L)
0 50 100 150 200 250
50
100
150
200
varying frequency
0 50 100 150 200
0
50
100
150
time (min)
 
 
RMSSD
0 50 100 150 200 250
0
50
100
150
 
 
FIG. 9. Computed RMSSD with a sampling frequency of 4 Hz and BD for UCOs with
varying occlusion degrees (left) and varying frequencies (right). Patterns of FHR (top),
RMSSD and BD (middle), and the corresponding representative experimental results [46] and [47]
(bottom). In the middle row, RMSSD is computed using 5-minute windows for the left column.
For the right column, RMSSD is computed using both 3- (cross-symbol) and 5-minute (dashed
line) windows.
our FHR output
RMSSD =
√√√√ 1
N − 1
(∑
i
Di
)
, (57)
where Di = |Pi+1 − Pi|2 with Pi the period between two maximum peaks and N is the
number of intervals within a certain window. For the case in the left column of Fig. 9,
where the frequency is varying, the computed RMSSD qualitatively captures the trend of
experimental data, which is displayed in the bottom panel (the discrepancy in magnitude is
due to sampling frequency). As occlusion proceeds, RMSSD increases monotonically. The
contingency tables do not exhibit significant correlation for this case. However, based on our
pH and BD results, we obtain significant increase in RMSSD when acidosis occurs, compared
to the baseline values.
In contrast, RMSSD is overestimated for moderate occluded UCOs as soon as occlusion
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occurs (middle right panel using 5-minute window as indicated by the dashed line) while no
obvious increase is observed afterwards. This is similar to a representative set of experimental
data [47] (bottom right panel).
Interestingly, if we reduce the window size, the computed RMSSD evolves very differently.
For example, RMSSD using a 3-minute window (cross-symbols, middle right panel of Fig. 9)
gradually increases as UCOs proceed and acidosis develops. This suggests that, in addition
to the importance of sampling frequency [48], a proper window size is also important.
IV. CONCLUDING REMARKS
We have investigated the cardiovascular and metabolic responses to UCOs in a fetal sheep
circulation using a mathematical model. Our model comprises a cardiovascular circuit, a
simplified metabolic model, and nervous control of blood pressure and oxygen content by
baro- and chemoreceptors [18, 23, 28]. Waste accumulation in the systemic compartment,
such as CO2 and lactate, is solved simultaneously with the cardiovascular response.
Our mathematical model produces the pattern observed in animal experiments, including
FHR decrease and overshoot, MABP and pH decline, and increased levels of lactate and
CO2. In particular, the development of the cardiovascular and metabolic responses in our
model are the result of sufficiently long lasting repetitive occlusions. In other words, acidosis
depends on the total duration of occlusion rather than on an individual event, as in [17].
In addition, the FHR decrease, FHR overshoot, and MABP response evolve accordingly to
observations obtained using various experimental scenarios. In particular, our results from
1:5 and 1:2.5 UCO demonstrate the possibility that properly functioning effectors (cardiac
contractility, systemic resistance, and venous compliance) are able to main the blood pressure
level and avoid instabilities in FHR. Our simplified metabolic model reproduces measured
changes in pH, lactate, and glucose. Although expected correlation between FHR overshoot,
MABP decline, and acidosis (quantified by BD) can be obtained when the occlusion is
complete, our results suggest that the correlation analysis may fail when the UCO degree
varies significantly. In that case, we show RMSSD is able to qualitatively predict acidemia.
The choice of window size is important in computing RMSSD when UCO frequency
varies. Uterine contractions during labour varies in frequency and degree. Therefore, the
usual choice of fixed window size may affect the results obtained in [48], in addition to the
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sampling frequency. A proper combination of FHR monitoring and RMSSD computation
may then be used to detect acidemia.
One limitation of our model is that, as other mathematical biology models in the litera-
ture, the parameter space is large, despite our effort to keep the model simple. Although the
sensitivity analysis has been carried out, physiological parameters are difficulty to estimate
accurately. We plan to use statistical modeling to control the uncertainty in parameters in
the future work [49]. Another limitation deals with the simplified metabolic process. A more
detailed model will potentially improve predictions of impaired supply of nutrients [50]. The
transport equations are used with relatively simple kinetic reaction terms involving only O2,
CO2, pyruvate, lactate, glucose and [H
+] in the systemic compartment. Nevertheless, more
experimental data will be needed to properly model the kinetics and regulation.
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TABLE I. Parameter values.
parameter (cardiovascular model) value parameter value
cf (mmHg/cm
3) 0.9 cm (mmHg/cm
3) 1.5
dm (mmHg) 1.1264 df 5
ψ (1/s) 0.05 Hm (1/s) 0.9
Ca (ml/mmHg) 0.8 Cv (mmHg s/ml
3) 3.5
Cum (ml/mmHg) 1.1 Cc (mmHg s/ml
3) 0.057
Ra (mmHg s/ml
3) 0.045 Rv (mmHg s/ml
3) 0.27
Rmc0 (mmHg s/ml
3) 1.5 Rumv (mmHg s/ml
3) 0.015
Rcv (mmHg s/ml
3) 0.015 Rcmc0 (mmHg s/ml
3) 10.485
parameter (regulation model) value parameter value
Rmc,min (mmHg s/ml
3) 0 Rmc,max 11.25
T0 (s) 0.406 Tv0 (s) 0.373
Ts0 (s) -0.177 PO2a,n (mmHg) 7.5
fevmin (1/s) 3.2 fevmax (1/s) 6.3
fesmin 2.66 fesmax 60
fes0 16.11 fesinf 2.1
fvn (1/s) 10 τgs (1/s) 0.05
fshn,0 (1/s) 8 τgv (1/s) 0.04
kes 0.0675 kev (mmHg
−1) 7.06
Wcv 0.2 Wbv 1
GT,s (s
2) -0.13 GT,v (s
2) 0.04
G′T,s (s
2) 0.046 δGT (s
2) 0.1235
τT,s (s) 6 τisc (s) 30
fac (mmHg) 11 fab,n (mmHg) 25
Gc 0.27 Gv -0.17
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TABLE II. Parameter values.
parameter (metabolic model) value parameter value
[O2]a,0 (ml
3 O2/ml
3 blood) 0.04 ka 0.005
Kf (ml
3 blood) 9.33 [O2]th (ml
3 O2/ml
3 blood) 0.068
KCO2 (ml
3 O2/ml
3 blood/mmHg) 0.244 kCO2 (ml
3 O2/ml
3 blood) 0.007
DCO2 (ml CO2/s/mmHg) 0.1 kum (ml CO2/s) 0.2
GLa (mM) 1 LAa (mM) 0.8
Pya (mM) 0.12 [H
+]a (nM) 40
K1 (mM/s) 100 K2 (1/s) 40
K3 (1/s) 0.4 K4 (1/s) 4
K5 (1/s) 0.5 K6 (1/s) 10
K7 (10
−61/s) 55 K8 (nmol/s) 10
K9 (nM/s) 15 K10 (10
6 1/s) 0.2
TABLE III. Clinically relevant quantities.
Baseline case
physical quantity reference/target value model output
FHR (bpm) 135 [28], 163±5 [43] 148
mean fetal arterial p¯a (mmHg) 55± 5 [4], 46±2 [8] 52.5
umbilical PO2 (mmHg) 18 [28] 17.6
cerebral PO2 (mmHg) 10±1 [7] 12.3
systemic PCO2 (mmHg) 45.5±2 [4] 52.7± 0.9 [38, 43] 47.5
intervillous space PO2 (mmHg) 23.3 [28, 44] 23.2
systemic lactate (mM) 1.6±0.2 [38] 2.1
systemic pH 7.36± 0.1 [38], 7.4±0.01 [4] 7.25
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TABLE V. Contingency tables for 1:2.5 UCO. X represents for the binary series for FHR,
MABP and lactate from left to right respectively, while Y represents for BD.
Y = 0 Y = 1
X = 0 3303 266
X = 1 4 27
Y = 0 Y = 1
X = 0 3167 251
X = 1 140 42
Y = 0 Y = 1
X = 0 3204 31
X = 1 103 262
TABLE VI. Contingency tables for UCO with various frequencies. X represents for the
binary series for FHR, MABP and lactate from left to right respectively, while Y represents for
BD.
Y = 0 Y = 1
X = 0 3250 324
X = 1 4 22
Y = 0 Y = 1
X = 0 3137 304
X = 1 117 42
Y = 0 Y = 1
X = 0 3151 74
X = 1 103 272
TABLE VII. Contingency tables for UCO with various degrees. X represents for the binary
series for FHR, MABP and lactate from left to right respectively, while Y represents for BD.
Y = 0 Y = 1
X = 0 3220 376
X = 1 2 2
Y = 0 Y = 1
X = 0 3135 372
X = 1 87 6
Y = 0 Y = 1
X = 0 3118 92
X = 1 104 286
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